{"product_id":"benefit-risk-appraisal-of-medicines-john-wiley-sons-inc-9780470060858-a-systematic-approach-to-decision-making-sam-salek","title":"Benefit-Risk Appraisal of Medicines","description":"\u003cp\u003eDiscover the essential guide to understanding the complexities of benefit-risk appraisal in the pharmaceutical industry with \u003cstrong\u003eBenefit-Risk Appraisal of Medicines\u003c\/strong\u003e by \u003cstrong\u003eSam Salek\u003c\/strong\u003e. Published by \u003cstrong\u003eJohn Wiley \u0026amp; Sons Inc\u003c\/strong\u003e in 2009, this comprehensive hardback spans \u003cstrong\u003e304 pages\u003c\/strong\u003e and delves into the critical criteria necessary for assessing benefits and risks associated with medications.\u003c\/p\u003e \n\n\u003cp\u003eThis book not only reviews the current practices of benefit-risk assessment employed by drug regulatory authorities and the pharmaceutical sector but also introduces a groundbreaking Multi-Criteria Decision Analysis (MCDA) model. Sam Salek discusses the development and evaluation of this innovative model, shedding light on its significant implications for drug evaluation practices.\u003c\/p\u003e \n\n\u003cp\u003eWhether you are a healthcare professional, a policy maker, or a student in the field of pharmacology, this book is an invaluable resource for enhancing your understanding of risk assessment and decision-making in medicine.\u003c\/p\u003e","brand":"Sam Salek","offers":[{"title":"Default Title","offer_id":52252006351190,"sku":"9780470060858","price":115.13,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9780470060858.jpg?v=1767779794","url":"https:\/\/www.bookshop.ee\/products\/benefit-risk-appraisal-of-medicines-john-wiley-sons-inc-9780470060858-a-systematic-approach-to-decision-making-sam-salek","provider":"Bookshop","version":"1.0","type":"link"}